Chidamide With R-CHOP Regimen for de Novo, High Risk Diffuse Large B Cell Lymphoma (DLBCL): A Prospective, Signal Arm, Open Label Clinical Trial
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Tucidinostat (Primary) ; Cyclophosphamide; Etoposide; Prednisone; Rituximab; Vincristine
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 20 Aug 2017 Status changed from not yet recruiting to recruiting.
- 30 Jun 2017 New trial record